Pleasanton, CA – According to filings with the U.S. Securities and Exchange Commission, Apton Biosystems is raising $24,800,278.00 in new funding. Sources indicate as part of senior management Chief Technology Officer, Bryan Staker played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Apton Biosystems

Apton Biosystems, a multiomics, molecular diagnostics company, is focused on bringing ultra-sensitive cancer treatment monitoring and early cancer screening tests to market. Founded in 2012 by Bryan Staker, Apton is driven by his passion for measuring the small coupled with the knowledge that if we can measure a single molecule of cancer, then we can impact the lives of millions by catching cancer at its earliest stages. Apton’s rich IP portfolio and seed money in 2015 from Khosla Ventures drove the development of a commercial grade super-resolution scanner.

To learn more about Apton Biosystems, visit http://www.aptonbio.com/

Contact:
Bryan Staker, Chief Technology Officer
650-284-6992

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved